Consumers Union commends the Senate Finance Committee for its recent work uncovering FDA delays in acting against potentially dangerous prescription drugs – most notably Vioxx – despite growing evidence of unreasonable safety risks.
For 85 years CR has worked for laws and policies that put consumers first. Learn more about CR’s work with policymakers, companies, and consumers to help build a fair and just marketplace at TrustCR.org
Consumers Union commends the Senate Finance Committee for its recent work uncovering FDA delays in acting against potentially dangerous prescription drugs – most notably Vioxx – despite growing evidence of unreasonable safety risks.